Royal Bank of Canada’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.78M Buy
451,336
+377,861
+514% +$4.84M ﹤0.01% 2234
2025
Q1
$934K Buy
73,475
+25,542
+53% +$325K ﹤0.01% 3231
2024
Q4
$630K Sell
47,933
-2,176
-4% -$28.6K ﹤0.01% 3476
2024
Q3
$756K Buy
50,109
+5,231
+12% +$78.9K ﹤0.01% 3363
2024
Q2
$636K Buy
44,878
+1,576
+4% +$22.3K ﹤0.01% 3469
2024
Q1
$590K Sell
43,302
-1,230
-3% -$16.8K ﹤0.01% 3457
2023
Q4
$599K Buy
44,532
+3,921
+10% +$52.7K ﹤0.01% 3618
2023
Q3
$507K Buy
40,611
+7,717
+23% +$96.3K ﹤0.01% 3557
2023
Q2
$446K Buy
32,894
+1,284
+4% +$17.4K ﹤0.01% 3639
2023
Q1
$441K Sell
31,610
-6,365
-17% -$88.8K ﹤0.01% 3621
2022
Q4
$539K Buy
37,975
+4,933
+15% +$70K ﹤0.01% 3611
2022
Q3
$451K Sell
33,042
-4,657
-12% -$63.6K ﹤0.01% 3666
2022
Q2
$536K Buy
37,699
+1,353
+4% +$19.2K ﹤0.01% 3609
2022
Q1
$601K Sell
36,346
-1,394
-4% -$23.1K ﹤0.01% 3677
2021
Q4
$726K Buy
37,740
+3,896
+12% +$74.9K ﹤0.01% 3657
2021
Q3
$704K Sell
33,844
-5,489
-14% -$114K ﹤0.01% 3570
2021
Q2
$843K Buy
39,333
+1,170
+3% +$25.1K ﹤0.01% 3407
2021
Q1
$752K Buy
38,163
+2,506
+7% +$49.4K ﹤0.01% 3409
2020
Q4
$704K Sell
35,657
-5,019
-12% -$99.1K ﹤0.01% 3350
2020
Q3
$715K Buy
40,676
+9,079
+29% +$160K ﹤0.01% 3121
2020
Q2
$567K Sell
31,597
-6,797
-18% -$122K ﹤0.01% 3254
2020
Q1
$575K Buy
38,394
+2,770
+8% +$41.5K ﹤0.01% 3066
2019
Q4
$621K Buy
35,624
+556
+2% +$9.69K ﹤0.01% 3272
2019
Q3
$530K Buy
35,068
+4,344
+14% +$65.7K ﹤0.01% 3277
2019
Q2
$518K Sell
30,724
-249
-0.8% -$4.2K ﹤0.01% 3320
2019
Q1
$530K Buy
30,973
+9,008
+41% +$154K ﹤0.01% 3182
2018
Q4
$331K Buy
21,965
+5,256
+31% +$79.2K ﹤0.01% 3433
2018
Q3
$341K Sell
16,709
-1,190
-7% -$24.3K ﹤0.01% 3577
2018
Q2
$336K Sell
17,899
-3,009
-14% -$56.5K ﹤0.01% 3535
2018
Q1
$402K Sell
20,908
-1,959
-9% -$37.7K ﹤0.01% 3280
2017
Q4
$449K Sell
22,867
-6,176
-21% -$121K ﹤0.01% 3202
2017
Q3
$624K Buy
29,043
+9,693
+50% +$208K ﹤0.01% 2991
2017
Q2
$403K Buy
19,350
+2,060
+12% +$42.9K ﹤0.01% 3191
2017
Q1
$335K Buy
17,290
+3,235
+23% +$62.7K ﹤0.01% 3374
2016
Q4
$239K Buy
14,055
+2,351
+20% +$40K ﹤0.01% 3653
2016
Q3
$219K Sell
11,704
-1,873
-14% -$35K ﹤0.01% 3660
2016
Q2
$234K Buy
13,577
+1,472
+12% +$25.4K ﹤0.01% 3636
2016
Q1
$217K Sell
12,105
-4,212
-26% -$75.5K ﹤0.01% 3674
2015
Q4
$385K Buy
16,317
+2,966
+22% +$70K ﹤0.01% 3359
2015
Q3
$300K Sell
13,351
-1,349
-9% -$30.3K ﹤0.01% 3429
2015
Q2
$415K Sell
14,700
-8,843
-38% -$250K ﹤0.01% 3330
2015
Q1
$649K Sell
23,543
-5,290
-18% -$146K ﹤0.01% 2845
2014
Q4
$717K Sell
28,833
-906
-3% -$22.5K ﹤0.01% 2721
2014
Q3
$657K Buy
29,739
+10,592
+55% +$234K ﹤0.01% 2718
2014
Q2
$397K Buy
19,147
+3,162
+20% +$65.6K ﹤0.01% 3176
2014
Q1
$348K Sell
15,985
-807
-5% -$17.6K ﹤0.01% 3171
2013
Q4
$343K Buy
16,792
+326
+2% +$6.66K ﹤0.01% 3143
2013
Q3
$317K Sell
16,466
-2,728
-14% -$52.5K ﹤0.01% 3240
2013
Q2
$341K Buy
+19,194
New +$341K ﹤0.01% 2944